Literature DB >> 22153850

Low prevalence of Pneumocystis jirovecii lung colonization in Ugandan HIV-infected patients hospitalized with non-Pneumocystis pneumonia.

Steve M Taylor1, Steven R Meshnick, William Worodria, Alfred Andama, J Lucian Davis, Adithya Cattamanchi, Saskia den Boon, Samuel D Yoo, Carol D Goodman, Laurence Huang.   

Abstract

Pneumocystis jirovecii is an important opportunistic infection in human immunodeficiency virus (HIV)-infected patients. In the developed world, P. jirovecii epidemiology is marked by frequent colonization in immunosuppressed patients, but data on the prevalence of colonization are very limited in sub-Saharan Africa, where the majority of persons living with HIV reside. Our objective was to describe the epidemiology of P. jirovecii colonization among HIV-positive patients in a cross-sectional, hospital-based study of patients admitted with suspected pneumonia in Kampala, Uganda. P. jirovecii was detectable in bronchoalveolar lavage fluid from 7 (6%) of 124 consecutive patients with non-Pneumocystis pneumonia. Colonization was not associated with patient demographic or clinical information. This prevalence is substantially lower than in published studies in the developed world and suggests that there is a limited reservoir of organisms for clinical infections in this Ugandan population. These findings may partially explain the low incidence of Pneumocystis pneumonia in Uganda and other sub-Saharan African countries.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22153850      PMCID: PMC3308345          DOI: 10.1016/j.diagmicrobio.2011.10.009

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  19 in total

1.  Pneumocystis colonization in HIV-infected patients.

Authors:  Laurence Huang; Kristina Crothers; Alison Morris; Gena Groner; Melissa Fox; Joan R Turner; Cynthia Merrifield; Shary Eiser; Patrizia Zucchi; Charles B Beard
Journal:  J Eukaryot Microbiol       Date:  2003       Impact factor: 3.346

2.  Infection with Pneumocystis carinii is prevalent in healthy Gambian children.

Authors:  A E Wakefield; T J Stewart; E R Moxon; K Marsh; J M Hopkin
Journal:  Trans R Soc Trop Med Hyg       Date:  1990 Nov-Dec       Impact factor: 2.184

3.  Ineffectiveness of trimethoprim-sulfamethoxazole prophylaxis and the importance of bacterial and viral coinfections in African children with Pneumocystis carinii pneumonia.

Authors:  Shabir A Madhi; Clare Cutland; Kuraisha Ismail; Cathryn O'Reilly; Archana Mancha; Keith P Klugman
Journal:  Clin Infect Dis       Date:  2002-10-07       Impact factor: 9.079

4.  Limited asymptomatic carriage of Pneumocystis jiroveci in human immunodeficiency virus-infected patients.

Authors:  Ann E Wakefield; Austin R Lindley; Helen E Ambrose; Cecile-Marie Denis; Robert F Miller
Journal:  J Infect Dis       Date:  2003-03-06       Impact factor: 5.226

5.  Causes of lower respiratory infection in HIV-infected Ugandan adults who are sputum AFB smear-negative.

Authors:  W Worodria; M Okot-Nwang; S D Yoo; T Aisu
Journal:  Int J Tuberc Lung Dis       Date:  2003-02       Impact factor: 2.373

6.  Prevalence and clinical predictors of Pneumocystis colonization among HIV-infected men.

Authors:  Alison Morris; Lawrence A Kingsley; Gena Groner; Irina P Lebedeva; Charles B Beard; Karen A Norris
Journal:  AIDS       Date:  2004-03-26       Impact factor: 4.177

7.  Genetic variation in Pneumocystis carinii isolates from different geographic regions: implications for transmission.

Authors:  C B Beard; J L Carter; S P Keely; L Huang; N J Pieniazek; I N Moura; J M Roberts; A W Hightower; M S Bens; A R Freeman; S Lee; J R Stringer; J S Duchin; C del Rio; D Rimland; R P Baughman; D A Levy; V J Dietz; P Simon; T R Navin
Journal:  Emerg Infect Dis       Date:  2000 May-Jun       Impact factor: 6.883

8.  Serologic responses to epitopes of the major surface glycoprotein of Pneumocystis jiroveci differ in human immunodeficiency virus-infected and uninfected persons.

Authors:  Kieran R Daly; Carl J Fichtenbaum; Reiko Tanaka; Michael J Linke; Robert O'Bert; Timothy D Thullen; Michele S Hui; Alan G Smulian; Peter D Walzer
Journal:  J Infect Dis       Date:  2002-08-09       Impact factor: 5.226

9.  Pulmonary disease associated with the human immunodeficiency virus in Kigali, Rwanda. A fiberoptic bronchoscopic study of 111 cases of undetermined etiology.

Authors:  J Batungwanayo; H Taelman; S Lucas; J Bogaerts; D Alard; A Kagame; P Blanche; J Clerinx; P van de Perre; S Allen
Journal:  Am J Respir Crit Care Med       Date:  1994-06       Impact factor: 21.405

Review 10.  Current epidemiology of Pneumocystis pneumonia.

Authors:  Alison Morris; Jens D Lundgren; Henry Masur; Peter D Walzer; Debra L Hanson; Toni Frederick; Laurence Huang; Charles B Beard; Jonathan E Kaplan
Journal:  Emerg Infect Dis       Date:  2004-10       Impact factor: 6.883

View more
  6 in total

1.  Empiric TB Treatment of Severely Ill Patients With HIV and Presumed Pulmonary TB Improves Survival.

Authors:  Winceslaus Katagira; Nicholas D Walter; Saskia Den Boon; Nelson Kalema; Irene Ayakaka; Eric Vittinghoff; William Worodria; Adithya Cattamanchi; Laurence Huang; John Lucian Davis
Journal:  J Acquir Immune Defic Syndr       Date:  2016-07-01       Impact factor: 3.731

2.  Procalcitonin predicts mortality in HIV-infected Ugandan adults with lower respiratory tract infections.

Authors:  Sofya Tokman; Christopher F Barnett; Leah G Jarlsberg; Pam R Taub; Saskia den Boon; J Lucian Davis; Adithya Cattamanchi; William Worodria; Alan Maisel; Laurence Huang
Journal:  Respirology       Date:  2014-01-26       Impact factor: 6.424

3.  The prevalence of laboratory-confirmed Pneumocystis jirovecii in HIV-infected adults in Africa: A systematic review and meta-analysis.

Authors:  Nicola K Wills; David S Lawrence; Elizabeth Botsile; Mark W Tenforde; Joseph N Jarvis
Journal:  Med Mycol       Date:  2021-07-14       Impact factor: 4.076

4.  Low prevalence of Pneumocystis pneumonia (PCP) but high prevalence of pneumocystis dihydropteroate synthase (dhps) gene mutations in HIV-infected persons in Uganda.

Authors:  Steve M Taylor; Steven R Meshnick; William Worodria; Alfred Andama; Adithya Cattamanchi; J Lucian Davis; Samuel D Yoo; Patrick Byanyima; Sylvia Kaswabuli; Carol D Goodman; Laurence Huang
Journal:  PLoS One       Date:  2012-11-16       Impact factor: 3.240

5.  Multilocus microsatellite genotyping array for investigation of genetic epidemiology of Pneumocystis jirovecii.

Authors:  Christian M Parobek; Linda Y Jiang; Jaymin C Patel; Miriam J Alvarez-Martínez; Jose M Miro; William Worodria; Alfred Andama; Serena Fong; Laurence Huang; Steven R Meshnick; Steve M Taylor; Jonathan J Juliano
Journal:  J Clin Microbiol       Date:  2014-02-12       Impact factor: 5.948

6.  Serologic responses to recombinant Pneumocystis jirovecii major surface glycoprotein among Ugandan patients with respiratory symptoms.

Authors:  Robert J Blount; Leah G Jarlsberg; Kieran R Daly; William Worodria; J Lucian Davis; Adithya Cattamanchi; Kpandja Djawe; Alfred Andama; Judith Koch; Peter D Walzer; Laurence Huang
Journal:  PLoS One       Date:  2012-12-21       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.